Literature DB >> 3009257

Superoxide anion generating capacity of polymorphonuclear cells in patients with liver cirrhosis.

Y Shiratori, T Kawase, T Sugimoto.   

Abstract

The superoxide anion generating capacity of polymorphonuclear cells (PMNs) in patients with liver cirrhosis and the effect of lipopolysaccharide on rat PMNs were examined. Superoxide anion generating capacity of PMNs was measured as luminol-dependent photon emission (chemiluminescence) during phagocytosis of peptide in vitro. Chemiluminescence of PMNs from patients with liver cirrhosis was significantly enhanced compared with normal healthy volunteers, and endotoxemia was detected in 3 out of 20 cases of liver cirrhosis by the limulus gelatin test. Serial studies revealed that chemiluminescence of PMNs and endotoxin in plasma decreased after administration of polymyxin B (3 X 10(6) u/day). Chemiluminescence of rat PMNs was also markedly enhanced after the injection of lipopolysaccharide, and persisted for more than 8 days even though endotoxemia was not detected. These results indicate that the enhancement of chemiluminescence by PMNs is related to endotoxins spilling over from the liver in patients with liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009257     DOI: 10.1007/bf02775937

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  15 in total

1.  Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance.

Authors:  K Tarao; K So; T Moroi; T Ikeuchi; T Suyama
Journal:  Gastroenterology       Date:  1977-09       Impact factor: 22.682

2.  Increased superoxide anion production by immunologically activated and chemically elicited macrophages.

Authors:  R B Johnston; C A Godzik; Z A Cohn
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

3.  Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure.

Authors:  S P Wilkinson; V Arroyo; B G Gazzard; H Moodie; R Williams
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

4.  Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver.

Authors:  M Bjorneboe; H Prytz; F Orskov
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

5.  Bacterial and dietary antibodies in liver disease.

Authors:  D R Triger; M H Alp; R Wright
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

6.  Renal failure in the patient with cirrhosis. The role of active vasoconstriction.

Authors:  M Epstein; D P Berk; N K Hollenberg; D F Adams; T C Chalmers; H L Abrams; J P Merrill
Journal:  Am J Med       Date:  1970-08       Impact factor: 4.965

7.  Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis.

Authors:  H Prytz; J Holst-Christensen; B Korner; H Liehr
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

Review 8.  Aspects of free radical reactions in biological systems: aging.

Authors:  B E Leibovitz; B V Siegel
Journal:  J Gerontol       Date:  1980-01

9.  Proteolytic enzymes released by liver macrophages may promote hepatic injury in a rat model of hepatic damage.

Authors:  A Tanner; A Keyhani; R Reiner; G Holdstock; R Wright
Journal:  Gastroenterology       Date:  1981-04       Impact factor: 22.682

10.  Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide.

Authors:  M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  1 in total

1.  Decreased production of active oxygen species by neutrophils in patients with liver cirrhosis and hepatocellular carcinoma.

Authors:  K Itoh; A Nakao; W Kishimoto; T Itoh; A Harada; T Nonami; M Nakano; H Takagi
Journal:  Gastroenterol Jpn       Date:  1993-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.